BRIEF

By applying real-time PCR technology, the Hepatitis C Virus Genotype Diagnostic Kit (PCR-Fluorescence Probing) is designed for qualitative identification of HCV genotypes (including genotypes 1b, 1, 2, 3, 4, 5 and 6) from HCV RNA positive samples. The test results can be used as an aid in the identification of HCV genotypes and determination of an appropriate therapeutic treatment indicated for the above listed gentoypes. The results can be used only for clinical reference, and cannot be used as the only evidence for adjusting therapeutic drugs. Clinical symptoms and other laboratory test results should also be considered to comprehensively determine the patients treatment.

PARAMETERS

Product features	Parameter
Specimen Type	serum
Extraction Platform	Magnetic beads technologies
Genotype	1b, 1(1b, 1a), 2 (2a), 3 (3a, 3b), 4 (4a), 5 (5a), 6 (6a)
Internal Control	Plasmid
PCR Instrument	Mx3000P,Slan 96P
Sensitivity	1000 IU/mL
Spec.	12T

BRIEF

Hepatitis C Viral (HCV) RNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the quantification of HCV RNA in human serum or plasma. It is intended for use as an aid in the diagnosis of an HCV infection and observing drug efficacy. Hepatitis C is mainly caused by HCV infection and transmitted through blood. Chronic infection of HCV can lead to chronic inflammation of liver and fibrosis, and some patients may develop into liver cirrhosis, even Hepatocellular Carcinoma (HCC). It has huge harms on patients’ health and life quality, and has become a severe social and public health issue.

PARAMETERS

Product features	Parameter
Specimen Type	serum or plasma
Extraction Platform	Advanced magnetic beads technology
Genotype	HCV 1-6 genotype
Internal Control	Lentivirus particles
PCR Instrument	ABI 7500,SLAN-96P,QuantStudio 3/5,Roche Light Cycler 480
Sensitivity	12 IU/mL
Linear range	25—1.0E+08 IU/mL
Spec.	24T

BRIEF

Hepatitis B Viral (HBV) DNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the quantification of Human HBV DNA in human serum. It is intended for use as an aid in diagnosing an HBV infection and observing drug efficacy.

PERFORMANCE

Advanced magnetic beads technology HBV DNA detection and viral load measurement are essential for treatment decisions and patient monitoring. Sansure's HBV DNA test kit (MB) uses the advanced magnetic beads technology to extract HBV DNA from clinical serum or plasma.  Our technology achieved high sensitivity and wide linear range detection to meet of clinical diagnosis and follow-up needs. Highly conservative primer probe design Sansure primers and probes target select the highly conservative S gene of HBV, which can cover A-H genotypes and avoid missed detection. High-efficient quality control system HBV DNA test kit (MB) uses UNG enzyme + dUTP system to remove carry-over contamination to avoid a false positive result. HBV DNA test kit (MB) uses Internal Control HBV DNA test kit (MB) uses Internal Control is the full name to whole-process the HBV extraction and amplification process to avoid false negative results.

PARAMETERS

Product features	Parameter
Specimen Type	Serum，plasma
Extraction Platform	Advanced magnetic beads technology
Genotype	HBV A-H genotype
Internal Control	Lentivirus particles
PCR Instrument	ABI 7500,SLAN-96P,QuantStudio 3/5,Roche Light Cycler 480
Sensitivity	5 IU/mL
Linear range	20—2.0E+09 IU/mL
Spec.	48T